Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Clinical Lung Cancer|December 5, 2003
Hypersensitivity pneumonitis in advanced non-small-cell lung cancer patients receiving gemcitabine and paclitaxel: report of two cases and a review of the literatureFred J Kudrik, M Patricia Rivera, Paul L Molina, et al.Journal of Medical Economics|February 22, 2013
The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA)John F Reitan, Fred J Kudrik, Kayleen Fox, et al.Lung Cancer (Amsterdam, Netherlands)|March 25, 2018
Phase II trial of preoperative pemetrexed plus carboplatin in patients with stage IB-III nonsquamous non-small cell lung cancer (NSCLC)John D Hainsworth, David M Waterhouse, Kent C Shih, et al.Clinical Lung Cancer|March 26, 2017
Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage DiseaseMark A Socinski, Frederic J Kaye, David R Spigel, et al.Clinical Breast Cancer|October 9, 2012
Phase II study of gemcitabine and bevacizumab as first-line treatment in taxane-pretreated, HER2-negative, locally recurrent or metastatic breast cancerRachel Borson, Graydon Harker, James Reeves, et al.Blood|January 1, 2005
Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignanciesRobert Z Orlowski, Peter M Voorhees, Reynaldo A Garcia, et al.Pageof 1